Released May 4, 2017, after the close
10-Q filed May 4, 2017, 34 days after period end · 0001564590-17-008756
Q1 2017 · 10-Q
Revenue$102.74M$102.74M +4.1% vs Q1 2016−5.3% vs Q4 2016
Net Income-$2.65M-$2.65M N/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.15-$0.15 N/M vs Q1 2016N/M vs Q4 2016
Gross Profit$80,157,000+4.7%
Operating Income$5,919,000−16.3%
Operating Cash Flow-$10,899,000N/M
Free Cash Flowderived-$14,620,000N/M
Margins · derived
Gross margin78.0%+0.5 pt vs Q1 2016
Operating margin5.8%−1.4 pt vs Q1 2016
Net margin-2.6%−6.5 pt vs Q1 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $102.74M | $98.68M | $89.76M | $100.01M |
| Net Income | -$2.65M | $3.84M | -$8.38M | -$2.51M |
| EPS Diluted | -$0.15 | $0.20 | -$0.45 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR